Cargando…

Platelet Levels of High- and Mega-Dose Methylprednisolone Treatment in Acute Immune Thrombocytopenia

Detalles Bibliográficos
Autor principal:	Ayçiçek, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2015
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451491/ https://www.ncbi.nlm.nih.gov/pubmed/26316491 http://dx.doi.org/10.4274/tjh.2014.0436

Ejemplares similares

The Effect of Platelet and Mean Platelet Volume Levels on Standard-dose Methylprednisolone Treatment Response in Primary Immune Thrombocytopenia
por: KILICASLAN, Emrah, et al.
Publicado: (2023)

Intracranial hemorrhage after high-dose methylprednisolone in a child with acute immune thrombocytopenic purpura
por: Heitink-Pollé, Katja M. J., et al.
Publicado: (2011)

Effect of short-term, high-dose methylprednisolone on oxidative stress in children with acute immune thrombocytopenia
por: Cura, Musa, et al.
Publicado: (2016)

Thrombopoietin levels in Quebec platelet disorder—Implications for the mechanism of thrombocytopenia
por: Hayward, C. P. M., et al.
Publicado: (2018)

Persistence of Platelets Activation Prior to Second Doses of Covid-19 Vaccine After Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Roberge, Guillaume, et al.
Publicado: (2022)

Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia
por: Tao, Lili, et al.
Publicado: (2017)

Mega-Trials
por: De Bono, David
Publicado: (1995)

Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2018)

Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse
por: Möhn, Nora, et al.
Publicado: (2020)

Acute Painful Reversible Steroid Myopathy with IV Methylprednisolone
por: Maramattom, Boby Varkey, et al.
Publicado: (2021)

Signal transduction pathway involved in platelet activation in immune thrombotic thrombocytopenia after COVID-19 vaccination
por: Misasi, Roberta, et al.
Publicado: (2021)

Successful treatment of steroid-refractory immune thrombocytopenia with alemtuzumab
por: Jung, Chul Won, et al.
Publicado: (2016)

Megadose Methylprednisolone (MDMP) for Hemangiomatosis
por: Özsoylu, Şinasi
Publicado: (2012)

Megadose Methylprednisolone (MDMP) for Hemangiomatosis
por: Küpeli, Serhan, et al.
Publicado: (2012)

Climate change and coastal mega cities of India
por: Pandve, Harshal T
Publicado: (2010)

Mighty journals, mega trials, and modest points
por: Kumar, K.V.S. Hari, et al.
Publicado: (2016)

Decreased incidence of acute immune thrombocytopenia in children during the COVID-19 pandemic
por: Harama, Daisuke, et al.
Publicado: (2023)

Pregnancy and immune thrombocytopenia: New trends
por: Yavaşoğlu, İrfan, et al.
Publicado: (2020)

Drug-induced immune-mediated thrombocytopenia
por: Singh, Harpreet, et al.
Publicado: (2020)

Late but effective long-term response to splenectomy in the treatment of immune thrombocytopenia
por: Scaramucci, Laura, et al.
Publicado: (2013)

Megadose Methylprednisolone (MDMP) For Granulocytic Sarcoma (GS)
por: ÖZSOYLU, Şinasi
Publicado: (2013)

Prognostic value of high on-treatment platelet reactivity
por: Doğan, Ali, et al.
Publicado: (2017)

The study of transcriptome sequencing in childhood immune thrombocytopenia
por: Sun, Congcong, et al.
Publicado: (2019)

Immune Thrombocytopenia Following COVID-19 Vaccination
por: Isaac, Sangeetha, et al.
Publicado: (2022)

Primary immune thrombocytopenia responding to antithyroid treatment in a patient with Graves’ disease
por: Gill, Harinder, et al.
Publicado: (2010)

Airway Management of a Giant Encephalocele Using Mega Pillow
por: Puri, Sunaakshi, et al.
Publicado: (2021)

Methylprednisolone versus intravenous immune globulin as an initial therapy in adult primary immune thrombocytopenia
por: Kim, Chul Hee, et al.
Publicado: (2019)

Thrombocytopenia caused by low-dose heparin supplementation of parenteral nutrition solution
por: Lee, Eunyoung, et al.
Publicado: (2013)

FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia
por: Norris, Peter A. A., et al.
Publicado: (2020)

Covid-19 and Children with Immune Thrombocytopenia: Emerging Issues
por: Lassandro, Giuseppe, et al.
Publicado: (2020)

Immune Thrombocytopenia: A Rare Complication of Rabies Vaccine
por: Bansal, Sachin, et al.
Publicado: (2021)

Relapse of immune thrombocytopenia after COVID‐19 vaccination
por: van Dijk, Wobke E. M., et al.
Publicado: (2021)

Frequently Relapsing Post-COVID-19 Immune Thrombocytopenia
por: Serrano, Claudia, et al.
Publicado: (2021)

Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia()
por: Huang, Ching-Tai, et al.
Publicado: (2021)

Use of Single- or Two-dose Pulse Methylprednisolone in the Treatment of Acute Immune Thrombocytopenic Purpura
por: Turhan, Ayşe Bozkurt, et al.
Publicado: (2018)

Remarkable resolution of COVID-19-associated cerebral vasculitis with methylprednisolone
por: Benguerfi, S., et al.
Publicado: (2022)

Early, low-dose, short-term methylprednisolone decreased the mortality in critical COVID-19 patients: A multicenter retrospective cohort study
por: Ji, Jingjing, et al.
Publicado: (2021)

Management of COVID-19-related immune thrombocytopenia by rhTPO
por: Zhang, Xuzhao, et al.
Publicado: (2021)

Immune thrombocytopenia following vaccination during the COVID-19 pandemic
por: Choi, Philip Young-Ill, et al.
Publicado: (2021)

High-dose methylprednisolone pulse therapy for the treatment of patients with severe COVID-19: Results from a prospective observational study
por: Bui, Thinh N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s7j1vtse09m3su485l740m5pd2